Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor
Christine L. Hammond(University of Rochester), Collynn F. Woeller(University of Rochester)
Cited by 23
Related Papers
TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts
|Investigative Ophthalmology & Visual Science|2019|73
The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation
|American Journal Of Pathology|2016|49
The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts
|Scientific Reports|2020|28
Metformin inhibits PDGF signaling to suppress hyaluronan and IL-6 production in Thyroid Eye Disease
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0